Capsensixx AG (FRA:CPX) ROCE %: 43.12% (As of Dec. 2025)

What is Capsensixx AG ROCE %?

Capsensixx AG FRA:CPX 87 ROCE % is 43.12% as of Dec. 2025. GuruFocus rates FRA:CPX with a GF Score™ of 87/100 and a GF Value™ of €27.46 (Modestly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Capsensixx AG's annualized ROCE % for the quarter that ended in Dec. 2025 was 43.12%.

Capsensixx AG (FRA:CPX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Capsensixx AG ROCE % Related Terms

Capsensixx AG ROCE % Historical Data

* Premium members only.

The historical data trend for Capsensixx AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Capsensixx AG ROCE % Chart

Capsensixx AG Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

37.67

31.27

26.33

27.46

36.61

Capsensixx AG Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
ROCE %	Get a 7-Day Free Trial															26.31	27.53	26.97	28.96	43.12

87GF Score

Capsensixx AG FRA:CPX

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Capsensixx AG ROCE % Calculation

Capsensixx AG's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	10.974	/	( ( (58.526 - 28.616)	+	(79.342 - 49.302) )	/ 2 )
	=	10.974	/	( (29.91	+	30.04)	/ 2 )
	=	10.974	/	29.975
	=	36.61 %

Capsensixx AG's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2025 )		(Q: Jun. 2025 )		(Q: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2025 )		(Q: Jun. 2025 )		(Q: Dec. 2025 )
	=	13.14	/	( ( (49.008 - 18.095)	+	(79.342 - 49.302) )	/ 2 )
	=	13.14	/	( ( 30.913	+	30.04 )	/ 2 )
	=	13.14	/	30.4765
	=	43.12 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 43.12% mean?

Capsensixx AG (FRA:CPX) has a ROCE % of 43.12% as of Dec. 2025.

Is Capsensixx AG's ROCE % too high?

Capsensixx AG's current ROCE % is 43.12%. The Asset Management industry median ROCE % is 4.46. Capsensixx AG's value of 43.12% is 866.8% above this industry median. Overall, Capsensixx AG has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Capsensixx AG's ROCE % compare to BLK and BX?

Capsensixx AG's ROCE % of 43.12% can be compared against companies in the Asset Management industry. The industry median ROCE % is 4.46. Capsensixx AG's value of 43.12% is 866.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for an Asset Management company?

The median ROCE % among Asset Management companies is 4.46, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Capsensixx AG's current ROCE % of 43.12% is 866.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Asset Management industry, the median ROCE % is 4.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Capsensixx AG's current ROCE % is 43.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Capsensixx AG stock overvalued right now?

Based on GuruFocus' analysis, Capsensixx AG (FRA:CPX) is currently considered Modestly Undervalued. The stock's GF Value™ is €27.46, compared to a current price of €21.40 — trading 22.1% below its estimated fair value. The current ROCE % is 43.12% and 866.8% above the Asset Management industry median of 4.46. Capsensixx AG's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Capsensixx AG (FRA:CPX), the current ROCE % is 43.12% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Capsensixx AG (FRA:CPX) Overvalued in 2026?

Based on GuruFocus' analysis, Capsensixx AG stock appears to be undervalued. The current stock price of €21.40 is trading 22.1% below its estimated GF Value™ of €27.46. GuruFocus considers Capsensixx AG to be Modestly Undervalued.

Key valuation signals for FRA:CPX:

ROCE %: 43.12%
GF Value™: €27.46 vs. price of €21.40 (22.1% below fair value)
GF Score™: 87/100 with 5 warning signs
Industry Position: 866.8% above the Asset Management median

No single metric tells the full story. See the FRA:CPX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Capsensixx AG Business Description

Industry Financial Services Asset Management

Comparable Companies STU:SQL FRA:PEH FRA:2INV FRA:UCA1 XTER:PZS XTER:B7E HAM:IRPA XTER:LQAG HAM:LSNA HAM:C9T BLK BX OSTO:INVE A TSX:BN KKR TSX:BAM APO STT AMP LSE:III

Other Exchanges CPX:Germany

Address Bettinastrasse 57-59, Frankfurt, DEU, D-60325

Website https://www.capsensixx.de

Capsensixx AG is a provider of financial administration as a service. The company is divided into two segments namely Funds management, Administration and Accounting Segment which includes fund management and fund accounting; and Securitisations which provides Advisory services in the field of financial engineering, securitisation and provision of director and administrative services to corporate clients in Luxembourg.

87GF Score

Get the complete analysis for FRA:CPX

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.40

Price

€27.46

GF Value

View FRA:CPX Analysis

See ROCE % data for all stocks →